Swayam Prabha, MBA, PhD


Associate Professor, Cancer and Cellular Biology
Associate Professor, Fels Cancer Institute for Personalized Medicine

Educational Background

  • Fellowship, Medical Industry Leadership Institute, Minneapolis, MN
  • Fellowship, United States Government, Department of Defense
  • MBA, Healthcare Management, Carlson School of Management, Minneapolis, MN
  • PhD, University of Nebraska Medical Center, Omaha, NE
  • MS, Banaras Hindu University, India

Honors & Awards

  • Special Merit - Research, University of Minnesota, 2018
  • Special Merit - Research, University of Minnesota, 2017
  • Betty and Terry Nobel Gift for Ovarian Cancer Research, 2017
  • Consultant, Smiths Medical, 2014-2017
  • Special Merit - Research, University of Minnesota, 2015
  • First Place, Medtronic Interdisciplinary Case Competition to develop “Go-to Market” strategy, 2012
  • Medical Industry Leadership Institute Fellowship, 2010-2011
  • Norman and Bernice Harris award for excellence in cancer research, 2004
  • AAPS Graduate Symposium Award in Biotechnology, 2004
  • Norman and Bernice Harris award for excellence in cancer research, 2002
  • Pre-doctoral Fellowship awarded by the Department of Defense, USA, 2002-2005
  • Widaman Fellowship Supplement from University of Nebraska Medical Center, 2002-2005
  • Best oral presentation at Midwest Student Biomedical Research Forum, NE, 2004
  • First place Oral Presentation at Midwest Student Biomedical Research Forum, NE, 2001
  • Junior Research Fellowship awarded by University Grants Commission, India, 1997-1999

Research Interests

  • Translational research
  • Ovarian cancer
  • Targeted drug delivery
  • Cell based therapies
  • Nanoengineered stem cells therapeutics


My current efforts are focused on developing novel drug/gene delivery approaches to fulfill unmet therapeutic needs. My tenure in the pharmaceutical industry and involvement in the development of clinical formulations, several of which have been successfully approved by the FDA, have enabled a deeper understanding of what it takes to translate ideas and concepts from laboratory into a clinical drug product. I hope to utilize this knowledge to devise therapies that are highly effective and have fewer side effects for lung and ovarian cancers, both diseases with poor survival rates and in urgent need of novel therapeutic approaches.

Selected Publications

Additional Publications

1. Layek, B., Sehgal, D.*, Argenta, P., Panyam, J., & Prabha, S. (2019) Nanoengineering of Mesenchymal Stem Cells via Surface Modification for Efficient Cancer Therapy. Advanced Therapeutics. doi: 10.1002/adtp.201900043

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...